Clinical Trial Update: Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) [Phase 3]

View source ↗

Summary

Phase 3 SOLOIST-WHF trial assessing sotagliflozin effects on cardiovascular events in adults with type 2 diabetes and post-worsening heart failure; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Heart Failure, Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2022-10-28